Description
MK-2461 is an inhibitor of MET that also shows inhibition of FGFR and PDGFR. In animal models of glioblastoma and gastric cancer, MK-2461 exhibits anticancer chemotherapeutic activity, decreasing tumor growth and size.
Product Unit Size | Cost | Quantity | Stock |
---|
MK-2461 is an inhibitor of MET that also shows inhibition of FGFR and PDGFR. In animal models of glioblastoma and gastric cancer, MK-2461 exhibits anticancer chemotherapeutic activity, decreasing tumor growth and size.
Cas No. | 917879-39-1 |
---|---|
Purity | ≥99% |
Formula | C24H25N5N5S |
Formula Wt. | 495.55 |
Chemical Name | 9-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridine |
IUPAC Name | 9-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridine |
Synonym | MK2461 |
Solubility | DMSO 99 mg/mL (199.77 mM) Water Insoluble Ethanol Insoluble |
Appearance | Yellow Solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Katz JD, Jewell JP, Guerin DJ, et al. Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer. J Med Chem. 2011 Jun 23;54(12):4092-108. PMID: 21608528.
Pan BS, Chan GK, Chenard M, et al. MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor. Cancer Res. 2010 Feb 15;70(4):1524-33. PMID: 20145145.
Diterpene found in Anisomeles.
Fluoroquinolone; topoisomerase IV and bacterial...
GSK3 and AChE inhibitor, potential σ1 agonist....
Triterpene saponin found in species of Panax. <...
Fluoroquinolone; topoisomerase IV and bacterial...
Kavalactone originally found in Piper methystic...
Derivative of methyl caffeate, hydroxycinnamic ...
JAK1/2/3 inhibitor.
BCL-XL specific degrader
Endogenous peptide fragment, involved in vasoco...
Glycylcycline; protein synthesis inhibitor.
Sesquiterpene lactone derived from Artemesia.
Kavalactone originally found in Piper methystic...
Steroid; glucocorticoid agonist.
Potential PKD binding agent.
PARP inhibitor.
Synthetic antioxidant that induces phase II enz...
Peptide, substance P analog; NK agonist.
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
Fluoroquinolone; vacuolar H+ ATPase, topoisomer...